Search clinical trials for: HB-AS02V

Total 150 results

Henogen
GlaxoSmithKline

Completed

Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination

Hepatitis B

Belgium, Czech Republic, Hungary
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.

Malaria

Mozambique
Henogen
GlaxoSmithKline

Completed

A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.

Hepatitis B

Belgium, Czech Republic, Hungary
Johnson & Johnson Pte Ltd
Shanghai China-Norm Management Consulting co.,LTD; Shanghai Skin Disease Hospital

Completed

An 8-week Full Face HUT Clinical Trial for HydroBoost (2.0/3.0)

Adult Skin Healthy Signs

China
Hookipa Biotech GmbH

Recruiting

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

HPV-Related Squamous Cell Carcinoma

United States, Spain, Netherlands
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome

Post COVID-19 Syndrome

United States
Hope Biosciences
The University of Texas Health Science Center, Houston

Active, not recruiting

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy

Traumatic Brain Injury

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.

Parkinson Disease

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

United States
Hope Biosciences Stem Cell Research Foundation

No longer available

Individual Patient Expanded Access IND to Treat Polyneuropathy

Polyneuropathies

United States
Hope Biosciences
The University of Texas Health Science Center, Houston

No longer available

Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI

Spinal Cord Injury at C5-C7 Level

United States
Hookipa Biotech GmbH
Centre for Vaccinology Ghent - CEVAC

Completed

Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV

Cytomegalovirus Infection

Belgium
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.

Congenital Muscular Dystrophy Due to Lamin A/C Mutation

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Completed

A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19

COVID-19

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain.

Chronic Pain

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.

Osteo Arthritis Knee | Knee Pain Chronic

United States
Hope Biosciences

Completed

Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis (HB-adMSCs)

Rheumatoid Arthritis

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Withdrawn

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

Alzheimer Disease

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy

Cerebral Palsy

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)

System; Lupus Erythematosus

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND for the Treatment of Stroke

Stroke | Stroke, Ischemic

United States
Hookipa Biotech GmbH

Terminated

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer Metastatic

United States
Hookipa Biotech GmbH

Not yet recruiting

Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART

Human Immunodeficiency Virus (HIV) Infection

United States
China Medical University Hospital
National Science and Technology Council; SEHA Kidney Care; Asia University Hospital

Recruiting

Hb Scope: A Multi-Center Validation Trial

Hemodialysis | Hemoglobin

Taiwan, United Arab Emirates
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

"Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis"

Primary Lateral Sclerosis, Adult, 1

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy

United States
Memorial Sloan Kettering Cancer Center
Hookipa Biotech GmbH; Naveris

Recruiting

A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

HPV16+ Squamous Cell Carcinoma

United States
Hookipa Biotech GmbH

Terminated

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Completed

A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.

COVID-19

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S (MAL019)

Malaria, Falciparum

United States
University of Maryland, Baltimore

Completed

Hepatitis B Vaccine in Seniors

Hepatitis B Vaccination

United States
Shiraz University of Medical Sciences
Shahid Beheshti University of Medical Sciences

Completed

Effects a Honey Based Syrup on Blood Parameters in Patients With Breast Cancer

Breast Cancer

Iran, Islamic Republic of
National Institute of Allergy and Infectious Diseases...

Completed

An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV

HIV Infections

United States
GlaxoSmithKline

Completed

Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants

Malaria | Malaria Vaccines

Tanzania
Annecto LLC
Holy Redeemer Hospital

Terminated

Pilot Study Using Transcranial Electrostimulation (TESA-HB) Therapy for the Treatment of Depressive Symptoms (TESAHBPilot)

Mild to Moderate Depression

United States
Honeybrains Biotech LLC
Cognitive Research Corporation

Completed

Safety and Efficacy of HB-1 for Panic Disorder

Panic Disorder

United States
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults

Tuberculosis (TB)

Switzerland
Sangart

Completed

Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients

Shock, Hemorrhagic | Acidosis, Lactic | Shock, Traumatic

France, United Kingdom, South Africa, Germany
U.S. Army Medical Research and Development Command
National Institute of Allergy and Infectious Diseases (NIAID); GlaxoSmithKline and other collaborators

Completed

Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali

Plasmodium Falciparum Malaria

Mali
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.

Malaria

Mozambique
Hekabio

Completed

Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan

Breast Cancer | Head and Neck Cancer

Japan
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

Tuberculosis (TB)

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type b

Peru
U.S. Army Medical Research and Development Command
GlaxoSmithKline; United States Agency for International Development (USAID); Walter... and other collaborators

Completed

Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine

Malaria, Falciparum

Kenya
U.S. Army Medical Research and Development Command
GlaxoSmithKline; United States Agency for International Development (USAID); The...

Completed

A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults

Malaria

United States
PT Bio Farma

Completed

Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

Healthy

Indonesia
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences; United Memorial Medical Center; River Oaks Hospital and Clinics

Terminated

Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19

COVID-19

United States
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer

Pancreatic Cancer

United States
Beth Israel Deaconess Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation

Chronic Kidney Disease | End-stage Renal Disease

United States
University Hospital Inselspital, Berne

Completed

Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients

Anemia

Switzerland

Search clinical trials for: HB-AS02V

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations